targeted therapy option of erdafitinib in bladder cancer #oncology #cancer #2023
Published 1 year ago • 110 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
19:14
critical updates in kidney, prostate, and bladder cancer from asco 2023 with dr. toni choueiri
-
14:16
new emerging treatment options and targeted therapies for bladder cancer
-
5:24
case 3: fgfr-targeted therapy adverse events in bladder cancer
-
23:10
bladder cell cancer algorithm - oncbrothers (rohit & rahul gosain) with dr. andrea apolo
-
1:54
targeted therapy effective for patients with advanced bladder cancer and specific gene mutations
-
2:12
erdafitinib: one more tool for bladder cancer
-
7:18
case 3: experience with fgfr-targeted therapies in bladder cancer
-
47:25
beyond the emergence of targeted therapies and the treatment of bladder cancer
-
2:20
the role of erdafitinib in treating patients with bladder cancer
-
3:02
discussion on trial investigating erdafitinib in patients with urothelial cancer
-
2:14
how does targeted therapy treat bladder cancer?
-
9:43
integrating immuno-oncology and targeted therapy for bladder cancer in practice
-
1:27
thor-2 cohort 3 interim analysis: erdafitinib in intermediate-risk nmibc with fgfr3/2 alterations
-
0:57
dr. siefker-radtke on next steps with erdafitinib in bladder cancer
-
1:56
analyzing frontline options for patients with bladder cancer
-
4:42
arlene siefker-radtke, md, regarding the development of erdafitinib in bladder cancer
-
1:28
erdafitinib for bladder cancer: more to come following fda approval
-
0:49
evolving landscape of urothelial cancer treatment: erdafitinib or enfortumab vedotin?
-
2:15
tar-210 erdafitinib intravesical delivery system in non-muscle invasive bladder cancer